MACKENZIE FINANCIAL CORP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 192 filers reported holding HAEMONETICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$276,115
+4.0%
3,1650.0%0.00%
Q2 2023$265,480
-73.7%
3,165
-74.1%
0.00%
-100.0%
Q1 2023$1,009,302
+34.9%
12,197
+28.3%
0.00%
+100.0%
Q4 2022$747,962
+202.8%
9,510
+185.4%
0.00%
Q3 2022$247,000
+8.3%
3,332
-4.7%
0.00%
Q2 2022$228,000
+9.1%
3,498
+18.2%
0.00%
Q3 2021$209,000
-60.6%
2,959
-50.0%
0.00%
-100.0%
Q2 2020$530,000
-15.1%
5,922
-5.4%
0.00%
-50.0%
Q1 2020$624,000
-1.3%
6,262
+13.9%
0.00%0.0%
Q4 2019$632,000
-78.9%
5,500
-76.9%
0.00%
-75.0%
Q3 2019$3,001,000
+6.8%
23,793
+1.9%
0.01%
+14.3%
Q2 2019$2,810,000
-71.9%
23,350
-79.6%
0.01%
-70.8%
Q1 2019$10,014,000
-49.0%
114,475
-41.7%
0.02%
-53.8%
Q4 2018$19,632,000
-2.1%
196,225
+12.1%
0.05%
+6.1%
Q3 2018$20,057,000
+81.2%
175,050
+41.8%
0.05%
+75.0%
Q2 2018$11,069,000
+420.9%
123,430
+140.1%
0.03%
+180.0%
Q2 2013$2,125,00051,4000.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders